Put Options

22 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$309.38 - $337.38 $109 Million - $119 Million
351,300 New
351,300 $113 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $45.9 Million - $55.4 Million
170,800 Added 65.29%
432,400 $123 Million
Q4 2023

Feb 15, 2024

SELL
$255.7 - $288.46 $45.6 Million - $51.4 Million
-178,200 Reduced 40.52%
261,600 $75.3 Million
Q3 2023

Nov 07, 2023

BUY
$218.65 - $271.46 $55.7 Million - $69.2 Million
254,800 Added 137.73%
439,800 $118 Million
Q2 2023

Aug 03, 2023

SELL
$214.27 - $253.37 $2.27 Million - $2.69 Million
-10,600 Reduced 5.42%
185,000 $41.1 Million
Q1 2023

May 04, 2023

BUY
$225.79 - $275.2 $36.4 Million - $44.3 Million
161,000 Added 465.32%
195,600 $47.3 Million
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $7.92 Million - $10.1 Million
34,600 New
34,600 $9.09 Million
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $1.96 Million - $2.18 Million
8,400 Added 42.0%
28,400 $6.92 Million
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $7.88 Million - $9.18 Million
-35,500 Reduced 63.96%
20,000 $4.98 Million
Q4 2020

Feb 11, 2021

BUY
$216.38 - $257.67 $2.1 Million - $2.5 Million
9,700 Added 21.18%
55,500 $12.8 Million
Q2 2020

Aug 12, 2020

SELL
$197.81 - $242.74 $2.47 Million - $3.03 Million
-12,500 Reduced 21.44%
45,800 $10.8 Million
Q1 2020

May 13, 2020

SELL
$182.24 - $241.7 $31 Million - $41.1 Million
-170,200 Reduced 74.49%
58,300 $11.8 Million
Q4 2019

Feb 10, 2020

BUY
$189.21 - $243.2 $1.57 Million - $2.02 Million
8,300 Added 3.77%
228,500 $55.1 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $43.4 Million - $52 Million
-249,400 Reduced 53.11%
220,200 $42.6 Million
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $14.3 Million - $16.7 Million
85,500 Added 22.26%
469,600 $86.5 Million
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $17.7 Million - $19.9 Million
97,700 Added 34.11%
384,100 $73 Million
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $16.6 Million - $19.4 Million
93,100 Added 48.16%
286,400 $55.8 Million
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $2.72 Million - $3.07 Million
14,700 Added 8.23%
193,300 $40.1 Million
Q2 2018

Aug 14, 2018

SELL
$166.05 - $186.51 $10.4 Million - $11.7 Million
-62,900 Reduced 26.05%
178,600 $33 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $16.7 Million - $19.5 Million
98,400 Added 68.76%
241,500 $41.2 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $3.63 Million - $4.05 Million
21,500 Added 17.68%
143,100 $24.9 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $20.3 Million - $23.2 Million
121,600
121,600 $22.7 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.